EP3286176

CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    13.4.2016
  • EP published:
    15.1.2020
  • EP application number:
    16718016.5
  • Max expiry date:
    12.4.2036
  • Title:
    CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE

Timeline

Today
13.4.2016EP application
15.1.2020EP Publication

Owner

  • Name:
    Pfizer Inc.
  • Address:
    235 East 42nd Street, New York, NY 10017, US

Inventor

  • Name:
    HANSEN, Eric Christian
  • Address:
    Pawcatuck, Connecticut 06379, US
  • Name:
    SEADEEK, Christopher Scott
  • Address:
    West Lafayette, Indiana 47906, US

Priority

  • Number:
    201562152108 P
  • Date:
    24.4.2015
  • Country:
    US

Classification

  • Categories:
    C07D 401/04

Upload documents